Reckitt Benckiser Group (LON:RKT) Reaches New 12-Month Low at $5,376.00

Reckitt Benckiser Group plc (LON:RKTGet Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 5,376 ($66.02) and last traded at GBX 5,380 ($66.07), with a volume of 322199 shares trading hands. The stock had previously closed at GBX 5,456 ($67.00).

Reckitt Benckiser Group Trading Down 1.6 %

The firm’s 50-day moving average price is GBX 5,728 and its 200-day moving average price is GBX 5,906.80. The company has a quick ratio of 0.46, a current ratio of 0.54 and a debt-to-equity ratio of 93.88. The company has a market cap of £38.49 billion, a P/E ratio of 1,765.70, a price-to-earnings-growth ratio of 4.33 and a beta of 0.10.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.

Further Reading

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.